⌕
First Trust Nasdaq Pharmaceuticals ETF · FTXH · Nasdaq
A sector position · not Tenet-scored
Compare
$43.40−0.93%At close
$43.40−0.41 (−0.93%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

FTXH Holdings

FTXH holds 51 positions as of Nov 14, 2026; the largest are LLY at 8.3%, ABBV at 7.7% and JNJ at 7.2%.

Sources Fund holdings disclosures Fund disclosuresHoldings as of How we compute thisNot investment advice
Positions
51
as of Nov 14, 2026
Largest holding
LLY 8.3%
One position carries outsized weight. Check it fits your view.
Top-10 share
56.2%
Concentrated — its ten largest names are ~56% of the fund.

Weights exclude the cash/collateral sleeve (0.2%).

All 51 holdings

#TickerCompanyWeightCumulative · to 100.0%
1LLYEli Lilly and Company8.3%
8.3%
2ABBVAbbVie Inc.7.7%
16.0%
3JNJJohnson & Johnson7.2%
23.2%
4PFEPfizer Inc.6.8%
30.0%
5MRKMerck & Co., Inc.6.7%
36.6%
6VTRSViatris Inc.4.2%
40.8%
7REGNRegeneron Pharmaceuticals, Inc.4.0%
44.8%
8BIIBBiogen Inc.3.9%
48.7%
9GILDGilead Sciences, Inc.3.9%
52.6%
10AMGNAmgen Inc.3.6%
56.2%
11ZTSZoetis Inc.3.6%
59.8%
12UTHRUnited Therapeutics Corporation3.5%
63.3%
13VRTXVertex Pharmaceuticals Incorporated3.4%
66.7%
14INCYIncyte Corporation3.3%
69.9%
15BMYBristol-Myers Squibb Company3.1%
73.1%
16EXELExelixis, Inc.2.6%
75.7%
17JAZZJazz Pharmaceuticals Plc2.6%
78.2%
18ILMNIllumina, Inc.1.6%
79.9%
19MEDPMedpace Holdings, Inc.1.5%
81.4%
20HALOHalozyme Therapeutics, Inc.1.4%
82.7%
21NBIXNeurocrine Biosciences, Inc.1.3%
84.1%
22ELANElanco Animal Health Incorporated1.3%
85.4%
23BMRNBioMarin Pharmaceutical Inc.1.1%
86.5%
24CRLCharles River Laboratories International, Inc.1.1%
87.6%
25MRNAModerna, Inc.0.8%
88.3%
26ALNYAlnylam Pharmaceuticals, Inc.0.8%
89.1%
27AMRXAmneal Pharmaceuticals, Inc.0.6%
89.7%
28TGTXTG Therapeutics, Inc.0.6%
90.2%
29ADPTAdaptive Biotechnologies Corporation0.6%
90.8%
30ROIVRoivant Sciences Ltd.0.5%
91.3%
31SYRESpyre Therapeutics, Inc.0.5%
91.9%
32ORKAOruka Therapeutics, Inc.0.5%
92.4%
33LGNDLigand Pharmaceuticals Inc. (Class B)0.5%
92.9%
34TNGXTango Therapeutics, Inc.0.5%
93.4%
35KYMRKymera Therapeutics, Inc.0.5%
93.9%
36ALKSAlkermes Plc0.5%
94.4%
37GHGuardant Health, Inc.0.5%
94.8%
38TXG10X Genomics, Inc. (Class A)0.4%
95.3%
39CAICaris Life Sciences, Inc.0.4%
95.7%
40IOVAIovance Biotherapeutics, Inc.0.4%
96.2%
41PTGXProtagonist Therapeutics, Inc.0.4%
96.6%
42DNTHDianthus Therapeutics, Inc.0.4%
97.0%
43LQDALiquidia Technologies, Inc.0.4%
97.4%
44KRYSKrystal Biotech, Inc.0.4%
97.8%
45ELVNEnliven Therapeutics Inc.0.4%
98.2%
46TWSTTwist Bioscience Corporation0.4%
98.6%
47TVTXTravere Therapeutics, Inc.0.4%
98.9%
48CORTCorcept Therapeutics Inc.0.3%
99.2%
49ACADACADIA Pharmaceuticals Inc.0.3%
99.5%
50ARWRArrowhead Pharmaceuticals, Inc.0.3%
99.8%
51US Dollar0.2%
100.0%

What are FTXH's top holdings?

FTXH's five largest holdings as of Nov 14, 2026 are LLY at 8.3%, ABBV at 7.7%, JNJ at 7.2%, PFE at 6.8% and MRK at 6.7%.

How many holdings are in FTXH?

FTXH holds 51 positions as of Nov 14, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.